US 8735407
Purine derivatives as A3 adenosine receptor-selective agonists
granted A61PA61P11/06A61P13/12
Quick answer
US patent 8735407 (Purine derivatives as A3 adenosine receptor-selective agonists) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61P, A61P11/06, A61P13/12, A61P17/02, A61P19/02